John Freeman, DO
Pain Medicine · Scottsdale, AZNPI 1134104433
Payments from drug & device makers
Across 40 payments — averaging $95.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertiflex, Inc.$1K
- Boston Scientific$669
- Nevro Corp.$389
- Medtronic$378
- Abbott$355
- Astellas Pharma US Inc$200
- plus $324 from 4 others
What the payments were for
- Travel & lodging$1,70645%
- Food & beverage$1,90650%
- Education$2005%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertiflex, Inc. | 11 | $1,496 |
| Boston Scientific | 8 | $669 |
| Nevro Corp. | 8 | $389 |
| Medtronic | 5 | $378 |
| Abbott | 2 | $355 |
| Astellas Pharma US Inc | 2 | $200 |
| Averitas Pharma Inc. | 1 | $122 |
| Viiv Healthcare Company | 1 | $93 |
| SPR Therapeutics, Inc | 1 | $86 |
| Globus Medical | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Superion ISS$1,340
- GENERAL - THERAPIES$473
- PROCLAIM$181
- Proclaim IPG$174
- INCEPTIV$172
- INTELLIS ADAPTIVESTIM$169
- Omnia$145
- Senza$144
- Qutenza$122
How this compares
$3,812 in reported general payments places this provider in the 45th percentile of 180 pain medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydromorphone Hcl | 22 | $1,431 |
| Pregabalin | 64 | $1,159 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 48 | $890 |
| Gabapentin | 35 | $689 |
| Tramadol Hcl | 48 | $418 |
| Duloxetine Hcl | 14 | $289 |
| Oxycodone Hcl | 27 | $262 |
| Cyclobenzaprine Hcl | 11 | $57 |
| Diazepam | 12 | $15 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Scottsdale
- Tory McJunkinScottsdale$218K
- Vivek IyerScottsdale$70K
- Nikesh SethScottsdale$53K
- Matthew CrooksScottsdale$38K
- Avijit SharmaScottsdale$23K
- Natalie StrandScottsdale$22K
- Jason JensenScottsdale$21K
- Ashu GoyleScottsdale$10K
- Monica TorresScottsdale$8K
- Gobi ParamanandamPhoenix$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.